Literature DB >> 11470141

Potential of embryonic stem cells.

A M Wobus1.   

Abstract

Embryonic stem (ES) cells are pluripotent cell lines established from undifferentiated embryonic cells characterized by nearly unlimited self-renewal and differentiation capacity. During differentiation in vitro, ES cells were found to be able to develop into specialized somatic cells types and to recapitulate processes of early embryonic development. These properties allow to use ES cells as model system for studying early embryonic development by gain- or loss-of-function approaches, or to investigate the effects of drugs and environmental factors on differentiation and cell function in embryotoxicity and pharmacology. Now, ES cells derived of human blastocysts may be used for the generation of somatic precursor or differentiated cells in cell and tissue therapy. The review presents data of mouse ES cell differentiation and gives an outlook on future perspectives and problems of using human ES cells in regenerative medicine.

Entities:  

Mesh:

Year:  2001        PMID: 11470141     DOI: 10.1016/s0098-2997(01)00006-1

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  34 in total

Review 1.  Embryonic stem cells.

Authors:  H J Rippon; A E Bishop
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

2.  Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway.

Authors:  Todd C McDevitt; Michael A Laflamme; Charles E Murry
Journal:  J Mol Cell Cardiol       Date:  2005-10-19       Impact factor: 5.000

Review 3.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

4.  A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells.

Authors:  Dachun Wang; David L Haviland; Alan R Burns; Eva Zsigmond; Rick A Wetsel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

5.  Development of a pluripotent ES-like cell line from Asian sea bass (Lates calcarifer)--an oviparous stem cell line mimicking viviparous ES cells.

Authors:  V Parameswaran; Ravi Shukla; Ramesh Bhonde; A S Sahul Hameed
Journal:  Mar Biotechnol (NY)       Date:  2007-08-18       Impact factor: 3.619

Review 6.  Stem cells technology: a powerful tool behind new brain treatments.

Authors:  Lucienne N Duru; Zhenzhen Quan; Talal Jamil Qazi; Hong Qing
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 7.  Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes.

Authors:  Patrizia Dell'Era; Patrizia Benzoni; Elisabetta Crescini; Matteo Valle; Er Xia; Antonella Consiglio; Maurizio Memo
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

8.  Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice.

Authors:  Dachun Wang; John E Morales; Daniel G Calame; Joseph L Alcorn; Rick A Wetsel
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

9.  Differential effects of retinoids and inhibitors of ERK and p38 signaling on adipogenic and myogenic differentiation of P19 stem cells.

Authors:  Frédéric Bouchard; Joanne Paquin
Journal:  Stem Cells Dev       Date:  2013-04-01       Impact factor: 3.272

Review 10.  The promise of stem cell research in pigs and other ungulate species.

Authors:  Bhanu Prakash V L Telugu; Toshihiko Ezashi; R Michael Roberts
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.